scholarly journals The effects of small monetary incentive upon human lever pressing rates

1967 ◽  
Vol 9 (4) ◽  
pp. 205-206 ◽  
Author(s):  
Paul G. Swingle ◽  
Donald Moors

1966 ◽  
Vol 4 (6) ◽  
pp. 209-210 ◽  
Author(s):  
Paul G. Swingle ◽  
Henry Coady ◽  
Donald Moors




1983 ◽  
Vol 20 (4) ◽  
pp. 439-442 ◽  
Author(s):  
Frederick Wiseman ◽  
Marianne Schafer ◽  
Richard Schafer

The authors describe an experimental study designed to determine the effects of a monetary incentive on (1) a potential respondent's decision to participate in a central-location interview, (2) that person's expressed willingness to participate in a future survey, and (3) the cost of data collection.



2021 ◽  
pp. 089011712110340
Author(s):  
Bhagyashree Katare ◽  
Shuoli Zhao ◽  
Joel Cuffey ◽  
Maria I. Marshall ◽  
Corinne Valdivia

Purpose: Describe preferences toward COVID-19 testing features (method, location, hypothetical monetary incentive) and simulate the effect of monetary incentives on willingness to test. Design: Online cross-sectional survey administered in July 2020. Subjects: 1,505 nationally representative U.S. respondents. Measures: Choice of preferred COVID-19 testing options in discrete choice experiment. Options differed by method (nasal-swab, saliva), location (hospital/clinic, drive-through, at-home), and monetary incentive ($0, $10, $20). Analysis: Latent class conditional logit model to classify preferences, mixed logit model to simulate incentive effectiveness. Results: Preferences were categorized into 4 groups: 34% (n = 517) considered testing comfort (saliva versus nasal swab) most important, 27% (n = 408) were willing to trade comfort for monetary incentives, 19% (n = 287) would only test at convenient locations, 20% (n = 293) avoided testing altogether. Relative to no monetary incentives, incentives of $100 increased the percent of testing avoiders (16%) and convenience seekers (70%) that were willing to test. Conclusion: Preferences toward different COVID-19 testing features vary, highlighting the need to match testing features with individuals to monitor the spread of COVID-19.



Field Methods ◽  
2021 ◽  
pp. 1525822X2198984
Author(s):  
April Y. Oh ◽  
Andrew Caporaso ◽  
Terisa Davis ◽  
Laura A. Dwyer ◽  
Linda C. Nebeling ◽  
...  

Behavioral research increasingly uses accelerometers to provide objective estimates of physical activity. This study extends research on methods for collecting accelerometer data among youth by examining whether the amount of a monetary incentive affects enrollment and compliance in a mail-based accelerometer study of adolescents. We invited a subset of adolescents in a national web-based study to wear an accelerometer for seven days and return it by mail; participants received either $20 or $40 for participating. Enrollment did not significantly differ by incentive amount. However, adolescents receiving the $40 incentive had significantly higher compliance (accelerometer wear and return). This difference was largely consistent across demographic subgroups. Those in the $40 group also wore the accelerometer for more time than the $20 group on the first two days of the study. Compared to $20, a $40 incentive may promote youth completion of mail-based accelerometer studies.



2021 ◽  
Vol 22 (5) ◽  
pp. 2397
Author(s):  
Chrysostomos Charalambous ◽  
Tereza Havlickova ◽  
Marek Lapka ◽  
Nina Puskina ◽  
Romana Šlamberová ◽  
...  

Cannabis/cannabinoids are widely used for recreational and therapy purposes, but their risks are largely disregarded. However, cannabinoid-associated use disorders and dependence are alarmingly increasing and an effective treatment is lacking. Recently, the growth hormone secretagogue receptor (GHSR1A) antagonism was proposed as a promising mechanism for drug addiction therapy. However, the role of GHS-R1A and its endogenous ligand ghrelin in cannabinoid abuse remains unclear. Therefore, the aim of our study was to investigate whether the GHS-R1A antagonist JMV2959 could reduce the tetrahydrocannabinol (THC)-induced conditioned place preference (CPP) and behavioral stimulation, the WIN55,212-2 intravenous self-administration (IVSA), and the tendency to relapse. Following an ongoing WIN55,212-2 self-administration, JMV2959 3 mg/kg was administered intraperitoneally 20 min before three consequent daily 120-min IVSA sessions under a fixed ratio FR1, which significantly reduced the number of the active lever-pressing, the number of infusions, and the cannabinoid intake. Pretreatment with JMV2959 suggested reduction of the WIN55,212-2-seeking/relapse-like behavior tested in rats on the twelfth day of the forced abstinence period. On the contrary, pretreatment with ghrelin significantly increased the cannabinoid IVSA as well as enhanced the relapse-like behavior. Co-administration of ghrelin with JMV2959 abolished/reduced the significant efficacy of the GHS-R1A antagonist in the cannabinoid IVSA. Pretreatment with JMV2959 significantly and dose-dependently reduced the manifestation of THC-induced CPP. The THC-CPP development was reduced after the simultaneous administration of JMV2959 with THC during conditioning. JMV2959 also significantly reduced the THC-induced behavioral stimulation in the LABORAS cage. Our findings suggest that GHS-R1A importantly participates in the rewarding/reinforcing effects of cannabinoids.





2011 ◽  
Vol 209 (4) ◽  
pp. 551-559 ◽  
Author(s):  
Pablo Mir ◽  
Iris Trender-Gerhard ◽  
Mark J. Edwards ◽  
Susanne A. Schneider ◽  
Kailash P. Bhatia ◽  
...  
Keyword(s):  


Sign in / Sign up

Export Citation Format

Share Document